Abstract

ObjectivesTo investigate the impact of ultrasound shear wave elastography (USWE) and multiparametric magnetic resonance imaging (mpMRI) in predicting a change in biopsy-assigned Gleason Score (GS) after radical surgery for localised prostate cancer (PCa).MethodA total of 212 men opting for laparoscopic radical prostatectomy (LRP) between September 2013 and June 2017 were recruited into this study. All the participants had 12-core transrectal ultrasound (TRUS) biopsies and imaging using USWE and mpMRI before radical surgery. The predictive accuracy for imaging modalities was assessed in relation to upgrading and downgrading of PCa GS between the biopsies and radical prostatectomy using Student’s t-test and multivariable logistic regression analyses. A decision analysis curve was constructed assessing the impact of nomogram on clinical situations using different thresholds of upgrading probabilities.ResultsMost GS 6 diseases on biopsies were upgraded on radical surgery (37/42, 88.1%). Major downgrading was seen in GS 8 category of disease (14/35; 37.1%), whereas no alteration was observed in GS 7 on biopsies in most men (55/75; 73.3%). In univariate analysis, higher preoperative prostate-specific antigen (PSA) (p = 0.001), higher prostate-specific antigen density (PSAD) (p = 0.002), stiffer USWE lesions (p = 0.009), and higher prostate imaging–reporting and data system (PIRADS) (p = 0.002) on mpMRI were significant predictors of upgrading. In multivariate logistic regression analyses, only PSA (p = 0.016) and USWE-measured tissue stiffness (p = 0.029) showed statistical significance in predicting upgrading.ConclusionsMeasurement of tissue stiffness using USWE in clinically localised PCa can predict upgrading of GS and has the potential to improve patient management options.

Highlights

  • The histological Gleason Score (GS) obtained using 12-core transrectal ultrasound (TRUS) biopsy informs risk stratification and counselling of clinically localised prostate cancer (PCa) patients regarding various treatment options

  • Two hundred and twelve patients opting for laparoscopic radical prostatectomy between September 2013 and June 2017 were recruited into this study

  • No change in Gleason Score was seen in 47.2% of all the cases (100/212)

Read more

Summary

Introduction

The histological Gleason Score (GS) obtained using 12-core transrectal ultrasound (TRUS) biopsy informs risk stratification and counselling of clinically localised prostate cancer (PCa) patients regarding various treatment options. The approach has significant limitations, as a large discrepancy exists between biopsy and postoperative radical prostatectomy GS in approximately 40% of all localised PCa patients especially for those with biopsy GS 6 disease [1,2,3]. Predicting GS prior to treatment of PCa becomes crucial, and the role of imaging as marker is less understood. There is still a burgeoning interest in investigating the role that imaging can play in predicting underestimated GS in biopsies. This will help in accurately assessing prognosis, treatment selection, and decision-making

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call